INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845PAB4 Class: CONV BD US

OAKTREE CAPITAL MANAGEMENT LP's Holding History (CIK: 0000949509)

Note: Option positions (PUT/CALL) are excluded.

Q3 2023
Shares 7,295,000 Value ($000) $7,195 Avg Close Range
Q2 2023
Shares 11,824,000 Value ($000) $9,509 Avg Close Range
Q1 2023
Shares 8,816,000 Value ($000) $7,289 Avg Close Range
Q4 2022
Shares 8,395,000 Value ($000) $6,300 Avg Close Range
Q3 2022
Shares 5,937,000 Value ($000) $4,484 Avg Close Range